Synakis

Toronto, Canada

Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.

$1.9M raised

May 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Synakis raised?

Synakis has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are Synakis's investors?

Synakis's investors include Ontario Centre of Innovation, UTEST.

Where is Synakis headquartered?

Synakis is headquartered in Toronto, Canada.

What does Synakis do?

Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.

What stage is Synakis at?

Synakis is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 11, 2026.

MLA

"Synakis — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/synakis. Accessed July 3, 2026.

APA

VCBacked. (2026). Synakis — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/synakis

Wikipedia (cite web)

{{cite web |title=Synakis — Funding & Investors |url=https://www.vcbacked.co/company/synakis |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 11, 2026.